{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:10:30Z","timestamp":1791803430600,"version":"4.3.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100015736","name":"Folkh\u00e4lsan Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015736","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"crossref","award":["1256107"],"award-info":[{"award-number":["1256107"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6 (FI)"},{"name":"Medicinska Underst\u00f6dsf\u00f6reningen Liv och H\u00e4lsa r.f (Life and Health Medical Fund)"},{"name":"Doctoral Program in Biomedicine"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12974-016-0764-7","type":"journal-article","created":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T13:22:57Z","timestamp":1480339377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Brain inflammation is accompanied by peripheral inflammation in Cstb \u2212\/\u2212 mice, a model for progressive myoclonus epilepsy"],"prefix":"10.1186","volume":"13","author":[{"given":"Olesya","family":"Okuneva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhilin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inken","family":"K\u00f6rber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saara","family":"Tegelberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarja","family":"Joensuu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Elina","family":"Lehesjoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,28]]},"reference":[{"key":"764_CR1","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1528-1167.2008.01546.x","volume":"49","author":"R K\u00e4lvi\u00e4inen","year":"2008","unstructured":"K\u00e4lvi\u00e4inen R, Khyuppenen J, Koskenkorva P, Eriksson K, Vanninen R, Mervaala E. Clinical picture of EPM1-Unverricht-Lundborg disease. Epilepsia. 2008;49:549\u201356.","journal-title":"Epilepsia"},{"key":"764_CR2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng0997-17","volume":"17","author":"MD Lalioti","year":"1997","unstructured":"Lalioti MD, Scott HS, Antonarakis SE. What is expanded in progressive myoclonus epilepsy? Nat Genet. 1997;17:17.","journal-title":"Nat Genet"},{"key":"764_CR3","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1101\/gr.6.11.1103","volume":"6","author":"LA Pennacchio","year":"1996","unstructured":"Pennacchio LA, Myers RM. Isolation and characterization of the mouse cystatin B gene. Genome Res. 1996;6:1103\u20139.","journal-title":"Genome Res"},{"key":"764_CR4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0014-5793(91)80804-C","volume":"285","author":"V Turk","year":"1991","unstructured":"Turk V, Bode W. The cystatins: protein inhibitors of cysteine proteinases. FEBS Lett. 1991;285:213\u20139.","journal-title":"FEBS Lett"},{"key":"764_CR5","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1111\/j.1582-4934.2010.01229.x","volume":"15","author":"D Haves-Zburof","year":"2011","unstructured":"Haves-Zburof D, Paperna T, Gour-Lavie A, Mandel I, Glass-Marmor L, Miller A. Cathepsins and their endogenous inhibitors cystatins: expression and modulation in multiple sclerosis. J Cell Mol Med. 2011;15:2421\u20139.","journal-title":"J Cell Mol Med"},{"key":"764_CR6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0014-5793(96)00984-2","volume":"395","author":"B Lenarcic","year":"1996","unstructured":"Lenarcic B, Krizaj I, Zunec P, Turk V. Differences in specificity for the interactions of stefins A, B and D with cysteine proteinases. FEBS Lett. 1996;395:113\u20138.","journal-title":"FEBS Lett"},{"key":"764_CR7","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.placenta.2008.09.005","volume":"29","author":"C Luciano-Montalvo","year":"2008","unstructured":"Luciano-Montalvo C, Ciborowski P, Duan F, Gendelman HE, Melendez LM. Proteomic analyses associate cystatin B with restricted HIV-1 replication in placental macrophages. Placenta. 2008;29:1016\u201323.","journal-title":"Placenta"},{"key":"764_CR8","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/glia.22760","volume":"63","author":"O Okuneva","year":"2015","unstructured":"Okuneva O, K\u00f6rber I, Li Z, Tian L, Joensuu T, Kopra O, Lehesjoki AE. Abnormal microglial activation in the Cstb(\u2212\/\u2212) mouse, a model for progressive myoclonus epilepsy, EPM1. Glia. 2015;63:400\u201311.","journal-title":"Glia"},{"key":"764_CR9","first-page":"215","volume":"161","author":"A Rinne","year":"1986","unstructured":"Rinne A, Jarvinen M, Dorn A, Alavaikko M, Jokinen K, Hopsu-Havu VK. Low-molecular cysteine protease inhibitors in the human palatal tonsil. Anat Anz. 1986;161:215\u201330.","journal-title":"Anat Anz"},{"key":"764_CR10","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.febslet.2014.01.015","volume":"588","author":"K Maher","year":"2014","unstructured":"Maher K, Zavrsnik J, Jeric-Kokelj B, Vasiljeva O, Turk B, Kopitar-Jerala N. Decreased IL-10 expression in stefin B-deficient macrophages is regulated by the MAP kinase and STAT-3 signaling pathways. FEBS Lett. 2014;588:720\u20136.","journal-title":"FEBS Lett"},{"key":"764_CR11","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1182\/blood.V96.7.2584","volume":"96","author":"T Suzuki","year":"2000","unstructured":"Suzuki T, Hashimoto S, Toyoda N, Nagai S, Yamazaki N, Dong HY, Sakai J, Yamashita T, Nukiwa T, Matsushima K. Comprehensive gene expression profile of LPS-stimulated human monocytes by SAGE. Blood. 2000;96:2584\u201391.","journal-title":"Blood"},{"key":"764_CR12","doi-asserted-by":"crossref","first-page":"31736","DOI":"10.1074\/jbc.M114.609396","volume":"289","author":"K Maher","year":"2014","unstructured":"Maher K, Jeric Kokelj B, Butinar M, Mikhaylov G, Mancek-Keber M, Stoka V, Vasiljeva O, Turk B, Grigoryev SA, Kopitar-Jerala N. A role for stefin B (cystatin B) in inflammation and endotoxemia. J Biol Chem. 2014;289:31736\u201350.","journal-title":"J Biol Chem"},{"key":"764_CR13","doi-asserted-by":"crossref","first-page":"28077","DOI":"10.1074\/jbc.271.45.28077","volume":"271","author":"L Verdot","year":"1996","unstructured":"Verdot L, Lalmanach G, Vercruysse V, Hartmann S, Lucius R, Hoebeke J, Gauthier F, Vray B. Cystatins up-regulate nitric oxide release from interferon-gamma-activated mouse peritoneal macrophages. J Biol Chem. 1996;271:28077\u201381.","journal-title":"J Biol Chem"},{"key":"764_CR14","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/j.febslet.2005.03.002","volume":"579","author":"N Kopitar-Jerala","year":"2005","unstructured":"Kopitar-Jerala N, Schweiger A, Myers RM, Turk V, Turk B. Sensitization of stefin B-deficient thymocytes towards staurosporin-induced apoptosis is independent of cysteine cathepsins. FEBS Lett. 2005;579:2149\u201355.","journal-title":"FEBS Lett"},{"key":"764_CR15","doi-asserted-by":"crossref","first-page":"11330","DOI":"10.1523\/JNEUROSCI.0677-12.2012","volume":"32","author":"L Sun","year":"2012","unstructured":"Sun L, Wu Z, Hayashi Y, Peters C, Tsuda M, Inoue K, Nakanishi H. Microglial cathepsin B contributes to the initiation of peripheral inflammation-induced chronic pain. J Neurosci. 2012;32:11330\u201342.","journal-title":"J Neurosci"},{"key":"764_CR16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.matbio.2005.10.005","volume":"25","author":"T Laitala-Leinonen","year":"2006","unstructured":"Laitala-Leinonen T, Rinne R, Saukko P, V\u00e4\u00e4n\u00e4nen HK, Rinne A. Cystatin B as an intracellular modulator of bone resorption. Matrix Biol. 2006;25:149\u201357.","journal-title":"Matrix Biol"},{"key":"764_CR17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bonr.2015.10.002","volume":"3","author":"O Manninen","year":"2015","unstructured":"Manninen O, Puolakkainen T, Lehto J, Harittu E, Kallonen A, Peura M, Laitala-Leinonen T, Kopra O, Kiviranta R, Lehesjoki AE. Impaired osteoclast homeostasis in the cystatin B-deficient mouse model of progressive myoclonus epilepsy. Bone Reports. 2015;3:76\u201382.","journal-title":"Bone Reports"},{"key":"764_CR18","doi-asserted-by":"crossref","first-page":"5910","DOI":"10.1523\/JNEUROSCI.0682-09.2009","volume":"29","author":"MK Lehtinen","year":"2009","unstructured":"Lehtinen MK, Tegelberg S, Schipper H, Su H, Zukor H, Manninen O, Kopra O, Joensuu T, Hakala P, Bonni A, Lehesjoki AE. Cystatin B deficiency sensitizes neurons to oxidative stress in progressive myoclonus epilepsy, EPM1. J Neurosci. 2009;29:5910\u20135.","journal-title":"J Neurosci"},{"key":"764_CR19","doi-asserted-by":"crossref","first-page":"10078","DOI":"10.1074\/jbc.M109.034793","volume":"285","author":"S Ceru","year":"2010","unstructured":"Ceru S, Konjar S, Maher K, Repnik U, Krizaj I, Bencina M, Renko M, Nepveu A, Zerovnik E, Turk B, Kopitar-Jerala N. Stefin B interacts with histones and cathepsin L in the nucleus. J Biol Chem. 2010;285:10078\u201386.","journal-title":"J Biol Chem"},{"key":"764_CR20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/3059","volume":"20","author":"LA Pennacchio","year":"1998","unstructured":"Pennacchio LA, Bouley DM, Higgins KM, Scott MP, Noebels JL, Myers RM. Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice. Nat Genet. 1998;20:251\u20138.","journal-title":"Nat Genet"},{"key":"764_CR21","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1148\/radiol.13122458","volume":"269","author":"O Manninen","year":"2013","unstructured":"Manninen O, Koskenkorva P, Lehtim\u00e4ki KK, Hypp\u00f6nen J, K\u00f6n\u00f6nen M, Laitinen T, Kalimo H, Kopra O, K\u00e4lvi\u00e4inen R, Gr\u00f6hn O, et al. White matter degeneration with Unverricht-Lundborg progressive myoclonus epilepsy: a translational diffusion-tensor imaging study in patients and cystatin B-deficient mice. Radiology. 2013;269:232\u20139.","journal-title":"Radiology"},{"key":"764_CR22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/NEN.0b013e31823e68e1","volume":"71","author":"S Tegelberg","year":"2012","unstructured":"Tegelberg S, Kopra O, Joensuu T, Cooper JD, Lehesjoki AE. Early microglial activation precedes neuronal loss in the brain of the Cstb\u2212\/\u2212 mouse model of progressive myoclonus epilepsy, EPM1. J Neuropathol Exp Neurol. 2012;71:40\u201353.","journal-title":"J Neuropathol Exp Neurol"},{"key":"764_CR23","doi-asserted-by":"crossref","first-page":"e0158195","DOI":"10.1371\/journal.pone.0158195","volume":"11","author":"I K\u00f6rber","year":"2016","unstructured":"K\u00f6rber I, Katayama S, Einarsdottir E, Krjut\u0161kov K, Hakala P, Kere J, Lehesjoki AE, Joensuu T. Gene-expression profiling suggests impaired signaling via the interferon pathway in Cstb\u2212\/\u2212 microglia. PLoS One. 2016;11:e0158195.","journal-title":"PLoS One"},{"key":"764_CR24","doi-asserted-by":"crossref","first-page":"e89321","DOI":"10.1371\/journal.pone.0089321","volume":"9","author":"T Joensuu","year":"2014","unstructured":"Joensuu T, Tegelberg S, Reinmaa E, Segerstr\u00e5le M, Hakala P, Pehkonen H, Korpi ER, Tyynel\u00e4 J, Taira T, Hovatta I, et al. Gene expression alterations in the cerebellum and granule neurons of Cstb(\u2212\/\u2212) mouse are associated with early synaptic changes and inflammation. PLoS One. 2014;9:e89321.","journal-title":"PLoS One"},{"key":"764_CR25","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1093\/brain\/awm118","volume":"130","author":"V Rigau","year":"2007","unstructured":"Rigau V, Morin M, Rousset MC, de Bock F, Lebrun A, Coubes P, Picot MC, Baldy-Moulinier M, Bockaert J, Crespel A, Lerner-Natoli M. Angiogenesis is associated with blood\u2013brain barrier permeability in temporal lobe epilepsy. Brain. 2007;130:1942\u201356.","journal-title":"Brain"},{"key":"764_CR26","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/978-1-61779-191-8_25","volume":"763","author":"M Kaya","year":"2011","unstructured":"Kaya M, Ahishali B. Assessment of permeability in barrier type of endothelium in brain using tracers: Evans blue, sodium fluorescein, and horseradish peroxidase. Methods Mol Biol. 2011;763:369\u201382.","journal-title":"Methods Mol Biol"},{"key":"764_CR27","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1099\/vir.0.83345-0","volume":"89","author":"JD Morrey","year":"2008","unstructured":"Morrey JD, Olsen AL, Siddharthan V, Motter NE, Wang H, Taro BS, Chen D, Ruffner D, Hall JO. Increased blood-brain barrier permeability is not a primary determinant for lethality of West Nile virus infection in rodents. J Gen Virol. 2008;89:467\u201373.","journal-title":"J Gen Virol"},{"key":"764_CR28","doi-asserted-by":"crossref","first-page":"e16601","DOI":"10.1371\/journal.pone.0016601","volume":"6","author":"S Garbuzova-Davis","year":"2011","unstructured":"Garbuzova-Davis S, Louis MK, Haller EM, Derasari HM, Rawls AE, Sanberg PR. Blood-brain barrier impairment in an animal model of MPS III B. PLoS One. 2011;6:e16601.","journal-title":"PLoS One"},{"key":"764_CR29","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/jnc.12939","volume":"132","author":"A Aggarwal","year":"2015","unstructured":"Aggarwal A, Khera A, Singh I, Sandhir R. S-nitrosoglutathione prevents blood-brain barrier disruption associated with increased matrix metalloproteinase-9 activity in experimental diabetes. J Neurochem. 2015;132:595\u2013608.","journal-title":"J Neurochem"},{"key":"764_CR30","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.it.2004.02.006","volume":"25","author":"P Romagnani","year":"2004","unstructured":"Romagnani P, Lasagni L, Annunziato F, Serio M, Romagnani S. CXC chemokines: the regulatory link between inflammation and angiogenesis. Trends Immunol. 2004;25:201\u20139.","journal-title":"Trends Immunol"},{"key":"764_CR31","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/35876","volume":"391","author":"MD Gunn","year":"1998","unstructured":"Gunn MD, Ngo VN, Ansel KM, Ekland EH, Cyster JG, Williams LT. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature. 1998;391:799\u2013803.","journal-title":"Nature"},{"key":"764_CR32","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1084\/jem.187.4.655","volume":"187","author":"DF Legler","year":"1998","unstructured":"Legler DF, Loetscher M, Roos RS, Clark-Lewis I, Baggiolini M, Moser B. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1\/CXCR5. J Exp Med. 1998;187:655\u201360.","journal-title":"J Exp Med"},{"key":"764_CR33","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.yfrne.2011.12.002","volume":"33","author":"MA Galic","year":"2012","unstructured":"Galic MA, Riazi K, Pittman QJ. Cytokines and brain excitability. Front Neuroendocrinol. 2012;33:116\u201325.","journal-title":"Front Neuroendocrinol"},{"key":"764_CR34","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.mcn.2012.06.004","volume":"53","author":"V Murta","year":"2013","unstructured":"Murta V, Ferrari CC. Influence of peripheral inflammation on the progression of multiple sclerosis: evidence from the clinic and experimental animal models. Mol Cell Neurosci. 2013;53:6\u201313.","journal-title":"Mol Cell Neurosci"},{"key":"764_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2014.08.007","volume":"44","author":"WA Banks","year":"2015","unstructured":"Banks WA. The blood-brain barrier in neuroimmunology: tales of separation and assimilation. Brain Behav Immun. 2015;44:1\u20138.","journal-title":"Brain Behav Immun"},{"key":"764_CR36","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1042\/BST20140319","volume":"43","author":"KD Rochfort","year":"2015","unstructured":"Rochfort KD, Cummins PM. The blood-brain barrier endothelium: a target for pro-inflammatory cytokines. Biochem Soc Trans. 2015;43:702\u20136.","journal-title":"Biochem Soc Trans"},{"key":"764_CR37","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1177\/1352458509107017","volume":"15","author":"ED Festa","year":"2009","unstructured":"Festa ED, Hankiewicz K, Kim S, Skurnick J, Wolansky LJ, Cook SD, Cadavid D. Serum levels of CXCL13 are elevated in active multiple sclerosis. Mult Scler. 2009;15:1271\u20139.","journal-title":"Mult Scler"},{"key":"764_CR38","doi-asserted-by":"crossref","first-page":"e0161656","DOI":"10.1371\/journal.pone.0161656","volume":"11","author":"K Kothur","year":"2016","unstructured":"Kothur K, Wienholt L, Mohammad SS, Tantsis EM, Pillai S, Britton PN, Jones CA, Angiti RR, Barnes EH, Schlub T, et al. Utility of CSF cytokine\/chemokines as markers of active intrathecal inflammation: comparison of demyelinating. Anti-NMDAR and Enteroviral Encephalitis. PLoS One. 2016;11:e0161656.","journal-title":"PLoS One"},{"key":"764_CR39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002559","volume":"3","author":"B Kuenz","year":"2008","unstructured":"Kuenz B, Lutterotti A, Ehling R, Gneiss C, Haemmerle M, Rainer C, Deisenhammer F, Schocke M, Berger T, Reindl M. Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosis. PLoS One. 2008;3:e2559.","journal-title":"PLoS One."},{"key":"764_CR40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12974-016-0507-9","volume":"13","author":"Z Liba","year":"2016","unstructured":"Liba Z, Kayserova J, Elisak M, Marusic P, Nohejlova H, Hanzalova J, Komarek V, Sediva A. Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid. J Neuroinflammation. 2016;13:55.","journal-title":"J Neuroinflammation"},{"key":"764_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2015.08.013","volume":"83","author":"KZ Chapman","year":"2015","unstructured":"Chapman KZ, Ge R, Monni E, Tatarishvili J, Ahlenius H, Arvidsson A, Ekdahl CT, Lindvall O, Kokaia Z. Inflammation without neuronal death triggers striatal neurogenesis comparable to stroke. Neurobiol Dis. 2015;83:1\u201315.","journal-title":"Neurobiol Dis"},{"key":"764_CR42","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/glia.22692","volume":"62","author":"N Esen","year":"2014","unstructured":"Esen N, Rainey-Barger EK, Huber AK, Blakely PK, Irani DN. Type-I interferons suppress microglial production of the lymphoid chemokine, CXCL13. Glia. 2014;62:1452\u201362.","journal-title":"Glia"},{"key":"764_CR43","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/glia.22944","volume":"64","author":"C Huang","year":"2016","unstructured":"Huang C, Sakry D, Menzel L, Dangel L, Sebastiani A, Kr\u00e4mer T, Karram K, Engelhard K, Trotter J, Sch\u00e4fer MK. Lack of NG2 exacerbates neurological outcome and modulates glial responses after traumatic brain injury. Glia. 2016;64:507\u201323.","journal-title":"Glia"},{"key":"764_CR44","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/brain\/awh680","volume":"129","author":"M Krumbholz","year":"2006","unstructured":"Krumbholz M, Theil D, Cepok S, Hemmer B, Kivis\u00e4kk P, Ransohoff RM, Hofbauer M, Farina C, Derfuss T, Hartle C, et al. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain. 2006;129:200\u201311.","journal-title":"Brain"},{"key":"764_CR45","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1128\/JVI.02154-14","volume":"89","author":"Q Chai","year":"2015","unstructured":"Chai Q, She R, Huang Y, Fu ZF. Expression of neuronal CXCL10 induced by rabies virus infection initiates infiltration of inflammatory cells, production of chemokines and cytokines, and enhancement of blood\u2013brain barrier permeability. J Virol. 2015;89:870\u20136.","journal-title":"J Virol"},{"key":"764_CR46","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/labinvest.2012.80","volume":"92","author":"TK Roberts","year":"2012","unstructured":"Roberts TK, Eugenin EA, Lopez L, Romero IA, Weksler BB, Couraud PO, Berman JW. CCL2 disrupts the adherens junction: implications for neuroinflammation. Lab Invest. 2012;92:1213\u201333.","journal-title":"Lab Invest"},{"key":"764_CR47","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.4049\/jimmunol.172.8.5034","volume":"172","author":"P Scapini","year":"2004","unstructured":"Scapini P, Morini M, Tecchio C, Minghelli S, Di Carlo E, Tanghetti E, Albini A, Lowell C, Berton G, Noonan DM, Cassatella MA. CXCL1\/macrophage inflammatory protein-2-induced angiogenesis in vivo is mediated by neutrophil-derived vascular endothelial growth factor-A. J Immunol. 2004;172:5034\u201340.","journal-title":"J Immunol"},{"key":"764_CR48","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.bbi.2010.10.002","volume":"25","author":"EK Rainey-Barger","year":"2011","unstructured":"Rainey-Barger EK, Rumble JM, Lalor SJ, Esen N, Segal BM, Irani DN. The lymphoid chemokine, CXCL13, is dispensable for the initial recruitment of B cells to the acutely inflamed central nervous system. Brain Behav Immun. 2011;25:922\u201331.","journal-title":"Brain Behav Immun"},{"key":"764_CR49","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.mcn.2005.03.005","volume":"29","author":"O Butovsky","year":"2005","unstructured":"Butovsky O, Talpalar AE, Ben-Yaakov K, Schwartz M. Activation of microglia by aggregated beta-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-gamma and IL-4 render them protective. Mol Cell Neurosci. 2005;29:381\u201393.","journal-title":"Mol Cell Neurosci"},{"key":"764_CR50","doi-asserted-by":"crossref","first-page":"6166","DOI":"10.4049\/jimmunol.164.12.6166","volume":"164","author":"CD Mills","year":"2000","unstructured":"Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. M-1\/M-2 macrophages and the Th1\/Th2 paradigm. J Immunol. 2000;164:6166\u201373.","journal-title":"J Immunol"},{"key":"764_CR51","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.imbio.2014.05.005","volume":"219","author":"R Mulder","year":"2014","unstructured":"Mulder R, Banete A, Basta S. Spleen-derived macrophages are readily polarized into classically activated (M1) or alternatively activated (M2) states. Immunobiology. 2014;219:737\u201345.","journal-title":"Immunobiology"},{"key":"764_CR52","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","volume":"41","author":"PJ Murray","year":"2014","unstructured":"Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, Gordon S, Hamilton JA, Ivashkiv LB, Lawrence T, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 2014;41:14\u201320.","journal-title":"Immunity"},{"key":"764_CR53","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.4049\/jimmunol.161.4.1837","volume":"161","author":"E Go\u00f1alons","year":"1998","unstructured":"Go\u00f1alons E, Barrachina M, Garc\u00eda-Sanz JA, Celada A. Translational control of MHC class II I-A molecules by IFN-gamma. J Immunol. 1998;161:1837\u201343.","journal-title":"J Immunol"},{"key":"764_CR54","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4049\/jimmunol.131.1.315","volume":"131","author":"DP King","year":"1983","unstructured":"King DP, Jones PP. Induction of Ia and H-2 antigens on a macrophage cell line by immune interferon. J Immunol. 1983;131:315\u20138.","journal-title":"J Immunol"},{"key":"764_CR55","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1084\/jem.176.1.287","volume":"176","author":"M Stein","year":"1992","unstructured":"Stein M, Keshav S, Harris N, Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med. 1992;176:287\u201392.","journal-title":"J Exp Med"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-016-0764-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T02:41:42Z","timestamp":1692585702000},"score":1,"resource":{"primary":{"URL":"http:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-016-0764-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,28]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["764"],"URL":"https:\/\/doi.org\/10.1186\/s12974-016-0764-7","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,28]]},"article-number":"298"}}